Trends & Forecasts

The true path to success as an entrepreneur is the ability to spot high impact problems – and to be fearless in the pursuit of great solutions.

Sitting Down With… Carsten Brockmeyer, CEO, Formycon, Germany.

How can we fight the global pandemic of falsified and substandard medicines?

The US Centers for Disease Control and Prevention has officially declared an “epidemic of prescription drug abuse”.

The stability of a protein sample and its tendency to aggregate is explored using a combination of SEC-MALS and DLS

A round-up of the latest expansion plans and new facilities as building fever grips the industry

Big pharma is turning to outside sources to fill pipelines, but how often are companies backing the wrong horse?

Rising drug prices are not helping the industry’s image problem.

Is pharma keeping up with the latest innovations? US legislators say no, and are looking to a new act to accelerate approvals.

Sitting Down With... Kiran Mazumdar-Shaw, Chairperson and Managing Director of Biocon, India.